Human regular U‐500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study

AIM: To compare the safety and efficacy of U500‐R delivered by a novel, specifically designed U500‐R insulin pump with U‐500R delivered by multiple daily injections (MDI). METHODS: The phase 3 VIVID study randomized people with type 2 diabetes to U‐500R by continuous subcutaneous insulin infusion (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Grunberger, George, Bhargava, Anuj, Ly, Trang, Zisser, Howard, Ilag, Liza L., Malone, James, Fan, Ludi, Zhang, Shuyu, Johnson, Jennal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065168/
https://www.ncbi.nlm.nih.gov/pubmed/31865633
http://dx.doi.org/10.1111/dom.13947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065168/
https://www.ncbi.nlm.nih.gov/pubmed/31865633
http://dx.doi.org/10.1111/dom.13947

Ejemplares similares